Search hospitals > New Jersey > New Brunswick

Saint Peter's University Hospital

Claim this profile
New Brunswick, New Jersey 08901
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Cancer
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
188 reported clinical trials
8 medical researchers
Photo of Saint Peter's University Hospital in New BrunswickPhoto of Saint Peter's University Hospital in New BrunswickPhoto of Saint Peter's University Hospital in New Brunswick

Summary

Saint Peter's University Hospital is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Tumors, Leukemia, Cancer, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. Saint Peter's University Hospital is involved with conducting 188 clinical trials across 393 conditions. There are 8 research doctors associated with this hospital, such as Nibal A. Zaghloul, Lisa A. Hopkins, Susan A. McManus, and Gopal R. Desai.

Area of expertise

1Tumors
Global Leader
Saint Peter's University Hospital has run 34 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Leukemia
Global Leader
Saint Peter's University Hospital has run 32 trials for Leukemia. Some of their research focus areas include:
Stage II
Philadelphia chromosome positive
BCR-ABL1 fusion positive

Top PIs

Clinical Trials running at Saint Peter's University Hospital

Breast Cancer
Osteosarcoma
Germ Cell Tumors
Non-Hodgkin's Lymphoma
Brain Tumor
Langerhans Cell Histiocytosis
Cancer
Neuroectodermal Tumors
Rhabdoid Tumor
Hepatoblastoma
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Symptom Monitoring

for Young Women on Hormone Therapy

This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint Peter's University Hospital?
Saint Peter's University Hospital is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Tumors, Leukemia, Cancer, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. Saint Peter's University Hospital is involved with conducting 188 clinical trials across 393 conditions. There are 8 research doctors associated with this hospital, such as Nibal A. Zaghloul, Lisa A. Hopkins, Susan A. McManus, and Gopal R. Desai.